Home » Topics » BioWorld Science

BioWorld Science
RSS

Inhibitor harms leukemic stem cells while boosting normal ones

June 23, 2022

Apellis and Affilogic expand R&D collaboration to include Nanofitins targeting TfR

June 23, 2022

Mindset Pharma collaborates with CAMH on preclinical evaluation of MSP-1014

June 23, 2022

CAIX-targeting radiopeptides show promise in preclinical models of cancer

June 23, 2022

VPAC receptor-specific Cu-67-TP-3805 shows theranostic potential for prostate cancer

June 23, 2022

Data in mice support potential of ATL-1102 for limb girdle muscular dystrophy R2

June 23, 2022

FGFR and PDGFR as targets for CNS tumors with BCOR alterations

June 23, 2022

Novel virus-like vaccine candidate against HERV-K shows promise in preclinical breast cancer

June 23, 2022

A novel Smad4-mutated mouse model of Myhre Syndrome

June 23, 2022

Pfizer identifies compounds targeting transthyretin

June 23, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...